Last updated 47 days ago

A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

500 patients around the world
Available in Argentina, United States
Pfizer
7Research sites
500Patients around the world
This study is for people with
Breast Cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Centro de Investigaciones Metabólicas (CINME) S.A. - CABA, Buenos Aires
Centro de Investigaciones Metabólicas (CINME) S.A. - CABA, Buenos Aires
Recruiting
Viamonte 2278, CABA, Buenos Aires
CIPREC Centro de Investigación y Prevención Cardiovascular - CABA
CIPREC Centro de Investigación y Prevención Cardiovascular - CABA
Recruiting
Av. Pueyrredon 1746, CABA, Buenos Aires
Organización Médica de Investigación (OMI)
Recruiting
Uruguay 725 PB , Buenos Aires, CP: 1015
Fundación Cori para la Investigación y Prevención del Cáncer - La Rioja
Recruiting
Dorrego 269, La Rioja
Sanatorio Norte SRL - Santiago del Estero
Recruiting
25 De Mayo 138, Santiago del Estero
Fundación Respirar
Recruiting
Av. Cabildo 1548, CABA, Buenos Aires
Fundación CENIT para la Investigación en Neurociencias
Recruiting
Juncal 2222, C1125 CABA, Argentina
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy